Matches in Nanopublications for { ?s ?p "DDI between Ziprasidone and Bromocriptine - The atypical antipsychotic, ziprasidone, may antagonize the effect of the dopamine agonist, bromocriptine. Consider alternate therapy or monitor for worsening of movement disorder. [drugbank_resource:DB00246_DB01200]"@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- drugbank_resource:DB00246_DB01200 label "DDI between Ziprasidone and Bromocriptine - The atypical antipsychotic, ziprasidone, may antagonize the effect of the dopamine agonist, bromocriptine. Consider alternate therapy or monitor for worsening of movement disorder. [drugbank_resource:DB00246_DB01200]" assertion.